Investment Summary

Organigram Invests In Hyasynth Biologicals

On December 22, 2021, Organigram invested in life science company Hyasynth Biologicals

Investment Highlights
  • This is Organigram’s 1st transaction in the Life Science sector.
  • This is Organigram’s 2nd transaction in Canada.
  • This is Organigram’s 2nd transaction in Quebec.

Investment Summary

Date 2021-12-22
Target Hyasynth Biologicals
Sector Life Science
Investor(s) Organigram
Deal Type Stake Purchase

Target

Hyasynth Biologicals

Montreal, Quebec, Canada
Hyasynth Biologicals is a producer of pure and sustainable products through fermentation. Hyasynth Biologicals was founded in 2014 and is based in Montreal, Quebec.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Organigram

Toronto, Ontario, Canada

Category Company
Founded 2010
Sector Consumer Products
Employees914
Revenue 160M CAD (2024)
DESCRIPTION

Organigram is a producer of cannabis and cannabis-derived products in Canada and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. Organigram was founded in 2010 and is based in Toronto, Ontario.


DEAL STATS #
Overall 2 of 4
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Quebec M&A 2 of 2
Country: Canada M&A 2 of 3
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-21 Laurentian Organic

Quebec, Canada

Laurentian Organic is a craft cannabis licensed producer. Laurentian Organic is based in Quebec, Canada.

Buy $36M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-25 Sanity Group

Berlin, Germany

Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany.

Buy -